Ortek Therapeutics
Setting a new standard for optimal oral health
Overview
Raised: $115,088
Rolling Commitments ($USD)
09/29/2022
$984
78
1998
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$445,252 |
$2,145,578 |
COGS |
$112,341 |
$1,174,308 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-614,548 |
$-230,189 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$981,561 |
$1,547,649 |
Accounts Receivable |
$0 |
$931,347 |
Total Assets |
$1,406,235 |
$2,014,889 |
Short-Term Debt |
$28,530 |
$22,638 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$28,530 |
$22,638 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual